Betting on the biotech comeback

Vantage Point: Driving Success in the Australian Market
15/04/2024 20 min Temporada 1 Episodio 15
Betting on the biotech comeback

Listen "Betting on the biotech comeback"

Descargar episodio

Episode Synopsis

Hashan De Silva, Founder and Managing Partner of new specialist healthcare fund KP Rx, speaks to Vantage Point about how his investment process has an edge in the life sciences sector, why now is the right time to invest, and the diverse experience he brings to to funds management.

More episodes of the podcast Vantage Point: Driving Success in the Australian Market

Investius: Talking Shop with Paul Sharbanee 25/10/2024
Calix - the Aussie company taking up the challenge of decarbonising the world’s biggest industries 09/02/2024
Chasing Alpha with Andrew Mitchell 25/01/2024
Data analytics driving a new era of online wagering with Stephen Crispe 03/08/2023
A Californian Cancer Killer Professor Yuman Fong and his work with Imugene 28/07/2023
Using AI to save lives on the roads: Acusensus’ Alexander Jannink 26/07/2023
An ASX company truly powering the circular economy: Close the Loop 25/07/2023
Chris Judd: AFL Champion to Fund Manager 25/07/2023
Tackling healthcare through the gut with Microba CEO, Dr Luke Reid 25/07/2023
Champion to CEO: The Grant Hackett Journey 23/05/2023
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA